OBJECTIVE: : The objective of the study is to evaluate whether high fasting blood glucose (FBG) in the non-diabetic range (<126 mg/dl) is associated with subclinical coronary atherosclerosis as determined by coronary artery calcium (CAC) independent of clustering of metabolic syndrome (MS) risk factors. METHODS & RESULTS: : Previously non-diabetic, 458 asymptomatic non-diabetic Brazilian men (mean age: 46+/-7 years, range: 29-65) underwent clinical consultation including FBG measurements and electron-beam tomography (EBT). The mean FBG of the study population was 88+/-10mg/dl. Overall, 190 (42%) of men had CAC>0. The prevalence of CAC was significantly higher among men with high-normal FBG (4th quartile: 94-125 mg/dl) versus normal FBG group (lower three quartiles: 66-93 mg/dl) (62% versus 35%, p<0.0001). In age adjusted analyses the odds ratio (OR) for any CAC among men with high-normal FBG versus normal FBG was 2.19 (95% CI: 1.33-3.58). On further adjustment for risk factors the relationship was slightly attenuated, however remained statistically significant (OR=1.78, 95% CI 1.05-3.00, p=0.03). In sub-stratified analyses high-normal FBG was associated with CAC among men without MS (OR: 1.99, 95% CI: 1.04-3.78) and with MS (OR: 2.12, 95% CI: 0.95-4.80). Similar relations with high-normal FBG were observed among individuals classified low risk (OR: 2.34, 95% CI: 1.14-4.83) as well intermediate high-risk men (OR: 1.95, 95% CI: 0.99-3.86) by Framingham risk score (FRS), respectively. CONCLUSIONS: : Fasting blood glucose in the upper normal range appears to be associated with the presence of CAC in apparently non-diabetic Brazilian men.
OBJECTIVE: : The objective of the study is to evaluate whether high fasting blood glucose (FBG) in the non-diabetic range (<126 mg/dl) is associated with subclinical coronary atherosclerosis as determined by coronary artery calcium (CAC) independent of clustering of metabolic syndrome (MS) risk factors. METHODS & RESULTS: : Previously non-diabetic, 458 asymptomatic non-diabetic Brazilian men (mean age: 46+/-7 years, range: 29-65) underwent clinical consultation including FBG measurements and electron-beam tomography (EBT). The mean FBG of the study population was 88+/-10mg/dl. Overall, 190 (42%) of men had CAC>0. The prevalence of CAC was significantly higher among men with high-normal FBG (4th quartile: 94-125 mg/dl) versus normal FBG group (lower three quartiles: 66-93 mg/dl) (62% versus 35%, p<0.0001). In age adjusted analyses the odds ratio (OR) for any CAC among men with high-normal FBG versus normal FBG was 2.19 (95% CI: 1.33-3.58). On further adjustment for risk factors the relationship was slightly attenuated, however remained statistically significant (OR=1.78, 95% CI 1.05-3.00, p=0.03). In sub-stratified analyses high-normal FBG was associated with CAC among men without MS (OR: 1.99, 95% CI: 1.04-3.78) and with MS (OR: 2.12, 95% CI: 0.95-4.80). Similar relations with high-normal FBG were observed among individuals classified low risk (OR: 2.34, 95% CI: 1.14-4.83) as well intermediate high-risk men (OR: 1.95, 95% CI: 0.99-3.86) by Framingham risk score (FRS), respectively. CONCLUSIONS: : Fasting blood glucose in the upper normal range appears to be associated with the presence of CAC in apparently non-diabetic Brazilian men.
Authors: Leslee J Shaw; Daniel S Berman; Roger S Blumenthal; Matthew J Budoff; Tracy L Faber; Tauqir Goraya; Sandra S Halliburton; Harvey Hecht; Hosen Kiat; Wolfgang Koenig; Shaista Malik; Michael Merhige; Khurram Nasir; James K Min; James O'Keefe; Donna M Polk; Paolo Raggi; Jeffrey A Rosenblatt; Ronald G Schwartz; Allen J Taylor; Gregory S Thomas; William Wijns Journal: J Nucl Cardiol Date: 2008 Jan-Feb Impact factor: 5.952
Authors: Andreas J Flammer; Mario Gössl; Jing Li; Yoshiki Matsuo; Martin Reriani; Darrell Loeffler; Robert D Simari; Lilach O Lerman; Sundeep Khosla; Amir Lerman Journal: J Clin Endocrinol Metab Date: 2012-09-26 Impact factor: 5.958
Authors: S Moebus; A Stang; S Möhlenkamp; N Dragano; A Schmermund; U Slomiany; B Hoffmann; M Bauer; M Broecker-Preuss; K Mann; J Siegrist; R Erbel; K-H Jöckel Journal: Diabetologia Date: 2008-11-01 Impact factor: 10.122
Authors: Tae Ryom Oh; Su Hyun Song; Hong Sang Choi; Sang Heon Suh; Chang Seong Kim; Ji Yong Jung; Kyu Hun Choi; Kook-Hwan Oh; Seong Kwon Ma; Eun Hui Bae; Soo Wan Kim Journal: J Pers Med Date: 2021-12-15
Authors: Martin K Rutter; Joseph M Massaro; Udo Hoffmann; Christopher J O'Donnell; Caroline S Fox Journal: Diabetes Care Date: 2012-07-06 Impact factor: 19.112
Authors: Katarzyna Janda; Marcin Krzanowski; Mariusz Gajda; Paulina Dumnicka; Danuta Fedak; Grzegorz J Lis; Piotr Jaśkowski; Jan A Litwin; Władysław Sułowicz Journal: Int J Endocrinol Date: 2013-12-18 Impact factor: 3.257